These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31914156)

  • 21. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approval of mifepristone (RU 486) in Europe.
    Sitruk-Ware R
    Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shaping the abortion policy - competing discourses on the Zambian termination of pregnancy act.
    Haaland MES; Haukanes H; Zulu JM; Moland KM; Michelo C; Munakampe MN; Blystad A
    Int J Equity Health; 2019 Jan; 18(1):20. PubMed ID: 30691459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Professional considerations for providing mifepristone-induced abortion.
    Fielding SL; Lee SS; Schaff EA
    Nurse Pract; 2001 Nov; 26(11):44-54. PubMed ID: 11759615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mifepristone in Italy: the case of a drug trapped between ethics and clinical practice.
    Banfi R; Pavone E; Cerri R; Menichetti M
    Pharm World Sci; 2007 Aug; 29(4):400-3. PubMed ID: 17342444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study.
    Dawson AJ; Nicolls R; Bateson D; Doab A; Estoesta J; Brassil A; Sullivan EA
    Reprod Health; 2017 Mar; 14(1):39. PubMed ID: 28288649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiprogestin drugs: ethical, legal and medical issues.
    Cook RJ; Grimes DA
    Law Med Health Care; 1992; 20(3):149-53. PubMed ID: 1434754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of early induced medical abortion with mifepristone when beginning progestin-only contraception on the same day.
    Douthwaite M; Candelas JA; Reichwein B; Eckhardt C; Ngo TD; Domínguez A
    Int J Gynaecol Obstet; 2016 Jun; 133(3):329-33. PubMed ID: 26969144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
    Bartley J; Tong S; Everington D; Baird DT
    Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
    Gomperts RJ; Jelinska K; Davies S; Gemzell-Danielsson K; Kleiverda G
    BJOG; 2008 Aug; 115(9):1171-5; discussion 1175-8. PubMed ID: 18637010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abortion pills: under whose control?
    Rowlands S
    J Fam Plann Reprod Health Care; 2012 Apr; 38(2):117-22. PubMed ID: 22454008
    [No Abstract]   [Full Text] [Related]  

  • 32. Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative study.
    Tsoi B; O'Reilly D; Masucci L; Drummond M; Goeree R
    J Popul Ther Clin Pharmacol; 2015; 22(1):e78-89. PubMed ID: 25715384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone for preventing pregnancy termination after initiation of medical abortion with mifepristone.
    Garratt D; Turner JV
    Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):472-475. PubMed ID: 29260618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requiring physicians to dispense mifepristone: an unnecessary limit on safety and access to medical abortion.
    Norman WV; Soon JA
    CMAJ; 2016 Dec; 188(17-18):E429-E430. PubMed ID: 27754893
    [No Abstract]   [Full Text] [Related]  

  • 35. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
    Guengant JP; Bangou J; Elul B; Ellertson C
    Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical methods of early abortion in developing countries. Consensus statement. The Population Council.
    Contraception; 1998 Nov; 58(5):257-9. PubMed ID: 9883380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health minister is stripped of his right to veto use of abortion pill.
    Zinn C
    BMJ; 2006 Feb; 332(7539):441. PubMed ID: 16497741
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-progesterones for the interruption of pregnancy.
    Bygdeman M; Van Look PF
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
    Petitet PH; Ith L; Cockroft M; Delvaux T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical abortion: the Tunisian experience.
    Hajri S
    Afr J Reprod Health; 2004 Apr; 8(1):63-9. PubMed ID: 15487615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.